ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

BSA Approves Provocative Questions RFA; NCI Announces Review of SAIC-Frederick, for caBIG Restructuring

June 24, 2011

Senate Bill Gives NIH $23.7 Billion, NCI $4.25 Billion, Better Than House.

November 2, 2001

Chart of FY 1991 Budget For NCI By Mechanism

February 2, 1990

Missouri Continues Breast Screening, Adds Other Tests

July 9, 1982

NCI To End CIS Partnership Program In 2010.

December 5, 2008